Department of Orthopedics, The Second Hospital of Jilin University, Changchun, China.
Department of Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China.
J Cell Physiol. 2019 Dec;234(12):22675-22686. doi: 10.1002/jcp.28834. Epub 2019 May 31.
During the human bone formation, the event of osteogenic differentiation of human bone mesenchymal stem cells (hBMSCs) is vital, and recent evidence has emphasized the important role of microRNAs (miRNAs) in osteogenic differentiation of hBMSCs. This study aims to examine the potential effects of miR-200c in osteogenic differentiation of hBMSCs and understand their underlying mechanisms. HBMSCs were obtained via human bone marrow. During osteogenic induction and differentiation, cells were transfected with different plasmids with the intention of investigating the roles of miR-200c on osteogenic differentiation, calcium salt deposition, alkaline-phosphatase (ALP) activity, mineralized nodule formation, osteocalcin (OCN) content, and proliferation of osteoblasts. Following transfection, dual luciferase reporter gene assay was conducted so as to explore the correlation between miR-200c and Myd88. Moreover, the AKT/β-Catenin signaling pathway was blocked with an AKT/β-Catenin inhibitor, AKTi, to investigate its involvement. The hBMSCs were successfully isolated from human bone marrow. Myd88 was determined as a target gene of miR-200c. Gain and loss-of-function assays confirmed that overexpression of miR-200c, or silencing of Myd88 promoted osteogenic differentiation, increased calcium salt deposition, ALP activity, mineralized nodule formation, and enhanced the proliferation of osteoblasts following osteogenic differentiation of hBMSCs. Meanwhile, the downregulation of miR-200c has been shown to have the opposite effect. Furthermore, these findings showed that the miR-200c overexpression activated the AKT/β-Catenin signaling pathway by targeting Myd88. To sum up, the miR-200c upregulation induces osteogenic differentiation of hBMSCs by activating the AKT/β-Catenin signaling pathway via the inhibition of Myd88, providing a target for treatment of bone repair.
在人类骨形成过程中,人骨髓间充质干细胞(hBMSCs)的成骨分化事件至关重要,最近的证据强调了 microRNAs(miRNAs)在 hBMSCs 成骨分化中的重要作用。本研究旨在探讨 miR-200c 对 hBMSCs 成骨分化的潜在影响,并了解其潜在机制。通过人骨髓获得 HBMSCs。在成骨诱导和分化过程中,用不同的质粒转染细胞,以研究 miR-200c 对成骨分化、钙盐沉积、碱性磷酸酶(ALP)活性、矿化结节形成、骨钙素(OCN)含量和成骨细胞增殖的作用。转染后,进行双荧光素酶报告基因检测,以探讨 miR-200c 与 Myd88 之间的相关性。此外,用 AKT/β-Catenin 抑制剂 AKTi 阻断 AKT/β-Catenin 信号通路,以研究其参与情况。成功地从人骨髓中分离出 hBMSCs。确定 Myd88 是 miR-200c 的靶基因。过表达 miR-200c 或沉默 Myd88 的功能丧失和获得功能实验证实,过表达 miR-200c 或沉默 Myd88 可促进 hBMSCs 成骨分化,增加钙盐沉积、ALP 活性、矿化结节形成,并增强成骨分化后成骨细胞的增殖。同时,下调 miR-200c 则产生相反的效果。此外,这些发现表明,miR-200c 通过抑制 Myd88 激活 AKT/β-Catenin 信号通路,从而上调,为骨修复治疗提供了一个靶点。总之,miR-200c 通过抑制 Myd88 激活 AKT/β-Catenin 信号通路,上调诱导 hBMSCs 成骨分化,为骨修复治疗提供了一个靶点。